tiprankstipranks
Trending News
More News >
aTyr Pharma (ATYR)
NASDAQ:ATYR
US Market
Advertisement

aTyr Pharma (ATYR) Technical Analysis

Compare
2,826 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
2Neutral
16Bearish
Technical Analysis Consensus
Neutral
4Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
aTyr Pharma’s (ATYR) Moving Averages Convergence Divergence (MACD) indicator is -0.29, suggesting aTyr Pharma is a Sell.
aTyr Pharma’s (ATYR) 20-Day exponential moving average is 1.08, while aTyr Pharma’s (ATYR) share price is $0.87, making it a Sell.
aTyr Pharma’s (ATYR) 50-Day exponential moving average is 2.00, while aTyr Pharma’s (ATYR) share price is $0.87, making it a Sell.

aTyr Pharma (ATYR) Pivot Points

Nov 02, 2025, 01:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.79
0.84
0.87
0.91
0.94
0.98
1.01
Fibonacci
0.84
0.87
0.89
0.91
0.94
0.96
0.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

aTyr Pharma (ATYR) Moving Averages

Nov 02, 2025, 01:01 AM
Period
Simple
Exponential
MA5
0.93Sell
0.92Sell
MA10
0.96Sell
0.95Sell
MA20
0.97Sell
1.08Sell
MA50
2.28Sell
2.00Sell
MA100
3.79Sell
2.90Sell
MA200
3.71Sell
3.22Sell
aTyr Pharma’s (ATYR) 10-Day exponential moving average is 0.95, while aTyr Pharma’s (ATYR) share price is $0.87, making it a Sell.
aTyr Pharma’s (ATYR) 100-Day exponential moving average is 2.90, while aTyr Pharma’s (ATYR) share price is $0.87, making it a Sell.
aTyr Pharma’s (ATYR) stock price is $0.87 and aTyr Pharma’s (ATYR) 50-day simple moving average is 2.28, creating a Sell signal.
aTyr Pharma’s (ATYR) stock price is $0.87 and aTyr Pharma’s (ATYR) 100-day simple moving average is 3.79, creating a Sell signal.
aTyr Pharma’s (ATYR) stock price is $0.87 and aTyr Pharma’s (ATYR) 200-day simple moving average is 3.71, creating a Sell signal.

aTyr Pharma (ATYR) Technical Indicators

Nov 02, 2025, 01:01 AM
Name
Value
Implied Action
RSI (14)
30.01
Neutral
STOCH (9,6)
8.84
Buy
STOCHRSI (14)
11.49
Buy
MACD (12,26)
-0.29
Sell
ADX (14)
29.29
Neutral
Williams %R
-98.29
Buy
CCI (14)
-117.44
Buy
ATR (14)
0.14
-
Ultimate Oscillator
28.95
Sell
ROC
-9.38
Sell
aTyr Pharma’s (ATYR) Relative Strength Index (RSI) is 30.01, creating a Neutral signal.
aTyr Pharma’s (ATYR) Trend Strength Indicator (ADX) is 29.29, creating a Neutral signal.
aTyr Pharma’s (ATYR) Commodity Channel Index (CCI) is -117.44, creating a Buy signal.
aTyr Pharma’s (ATYR) Price Rate of Change (ROC) is -9.38, creating a Sell signal.

FAQ

Is ATYR a Buy, Hold, or Sell?
Based on ATYR’s technical indicators, ATYR is a Strong Sell.
    What is ATYR’s RSI (14)?
    ATYR’s RSI (14) is 30.01, which suggests ATYR is a Neutral.
      What is ATYR’s MACD?
      ATYR’s MACD is -0.29, which suggests ATYR is a Sell.
        What is ATYR’s 5-day moving average?
        ATYR’s 5-day moving average is 0.93, which suggests ATYR is a Sell.
          What is ATYR’s 20-day moving average?
          ATYR 20-day moving average is 0.97, which suggests ATYR is a Sell.
            What is ATYR’s 50-day moving average?
            ATYR’s 50-day moving average is 2.28, which suggests ATYR is a Sell.
              What is ATYR’s 200-day moving average?
              ATYR’s 200-day moving average is 3.71, which suggests ATYR is a Sell.
                What is ATYR’s Williams % R (14)?
                ATYR’s Williams % R (14) is -98.29, which suggests ATYR is a Buy.
                  What is ATYR’s CCI (14)?
                  ATYR’s CCI (14) is -117.44, which suggests ATYR is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis